Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
AN RUO test can be purchased by any organisation , be it the WHO , any public health authority , uni , any lab anywhere around the globe.
The WHO have not yet put out a tender as they did with SARS -Cov-2 .
As an RUO it will be used for surveillance and as the WHO have already said many poorer nations flying blind. It can also be used to support other observations by clinicians should they so choose. I expect temp staff in as phone lines may be buzzing as the sales staff work with established networks to offer it to labs globally.
I'd agree, Sir Digby
The level of testing currently available globally is laughable and this will be partly due to the regulatory hurdles a company has to go through to get approval.
The map of MPX prevalence shown in the link shared by Ad4U earlier (https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html) is more to do with level of testing than with number of cases in the community - we already know it's been endemic in some African countries for a number of years, and that's not shown. As Kaeren said earlier, it may not always present itself with the more obvious postul symptoms., so there could be far more asymptomatic/semi-symptomatic cases in the population than we think.
So, contrary to my earlier email - this may not be a loss leader to show our capabilities afterall. DA did say he was going to focus R&D on where the money is; maybe he is being more true to his word than we realise - this could be rather lucrative if we manage another WHO tie-up. Remember the last one was for 10m just for covid testing in the Ukraine way be the conflict escalated.
I have a feeling we're not going to stay out of favour for too much longer and things may magically get resolved sooner than hoped.
GLA
Nova have tweeted saying its available for sale
I believe it will need an emergency use listing with WHO, not sure whether a CE mark is required for that. What I do know is that WHO have been promising to supply poorer countries with monkey pox assays WHEN they became available.
Good news on the two assays, there's a serious danger of MPX becoming endemic outside of Africa largely due to a lack of diagnostics and slow response from governments. If you don't belong to a vary narrow subset of the population then you can't get tested at the moment, all testing currently being done at PD. The US has been abysmal in their response.
hillseeker / B2HS2L / Kaeren
Does anyone know if the monkeypox PCR could be bought by WHO as it is for worldwide use even though the RNS states use for research purposes . Does it need to be CE marked ?
Let's hope it doesn't turn into an old Hollies Hit ( showing my age ).
Look it up.
Thanks Ventura! Looks like I have the Midas touch ;)
Joysbio... Monkeypox......... Uk likes chinease... Rubbish
Hi harchris... Yes if you swab liaison... Think a couple tests already out... Realiability not great....
Whist fully comprehending the WHO comments , I was thinking about Monkeypox testing in a different way entirely.
I have read numerous times that this can present in many forms with the clickbait huge lesions all over the body being an extreme case. I have read that Monkepox could have been in the community for longer then initially thought and lots of rashes were not identified as monkeypox . I was envisaging this as a test that would be widely adopted by STD clinics as one to tick off if other more widely spread STD's did not produce a positive result. Thoughts ?
Great to have you back HarChris. Missed your balanced view.
Keep the faith all.
Another good thing for our sales teams is that the Monkeypox assay is good for all our instruments, thus demonstrating that our previous customers just found yet another use for them.
Blow me down, how fortunate.
Is it possible to develop a LFT for this, - I guess we'll soon find out.
Exactly B2, view it as a loss-leader, demonstrating our expertise and agility.
I suspect they lost a few precious days at the start, taking too long to make the decision to go ahead knowing it wouldn't be that lucrative in the short term in terms of direct revenue but then realised it's such a high profile virus, the opportunity couldn't be missed to demonstrate capability - just my speculation.
Hillseeker -
I first thought that the development of a Monkeypox assay might not be profitable for us.
My next thought was that, committed as we are to being first global responder, and also with a need to impress a very good customer - the WHO, we need to show we are on top of Monkeypox, with the lid remaining screwed down via the bioinformatics team activities.
I see no reason why this should not happen.
I'm not expecting this to be very profitable unless the virus is not controlled in undeveloped countries, or the virus becomes much more contagious.
I bolstered my holding and bought a few shares back this morning. Why? Well after seeing 4D pharma go into administration last week it woke me up to how many others are sadly going to face the same fate if broader macroeconomic conditions don't improve. Novacyt's softly softly approach hasn't helped the SP up until now but we do sit in the envious position of being cash-rich and acquisition hungry just as those the company probably have had their eyes on potentially crumble in valuation over the coming months.
Add in the development with the counter claim and the narrative moving away from covid (whilst covid still rips through the country at the hottest time of the year) and it's easy to see value here.
Indeed 21ATS, news feeds will then pick this up.
Unless things get really bad with Monkey Pox, I cannot see huge revenues from the test in the near term - hence no sudden rise in SP, but it changes the narrative away form Covid and demonstrates our ability to tailor tests to the latest threat, which is completely inline with our global surveillance/first responder strategy from which large NGO or governmental contracts may ensue in the longer term.
It also reinforces the credibility of the long term plans. We are being asked to trust the company that they will return to 100m revenues in five years. Delivering on tests like this is just a small step in growing that credibility.
Covid remains a short to medium term revenue stream - the virus is clearly not abating. Revenue may struggle over the summer, but going into next winter we are in a strong position with our saliva LFT. There is too much money lost with time off work - is it covid or just a cold? Spit in here and be sure you are not putting colleagues at risk.
I'm feeling positive and looking forward to more of the same regarding news flow - I'm not holding my breath, but the DHSC coughing up is the biggy, which could drop any time, of course, and will completely change the sentiment. I'm sure there is so much going on behind the scenes that we are not aware of. I wouldn't be surprised if the final, out of court settlement is tied up with a new DHSC contract of sorts.
GLA - hanging on in there!
It seems the BOD have ignored us for too long. They need to open their ears.
'We continue to provide solutions for emerging and anticipated healthcare threats'.
Plugged into the bioinformatics teams automated equipment, we should see where any future mutations will take this disease. We can thus keep the Monkeypox virus in our rifle sites more easily and quickly than other manufacturers.
Great news, lets hope the likes of WHO like it as much.
"Ya know ya gonna neeeed a MyGo with that thar assay ya jus' bought"....
Aaaand the market doesn’t care. Ffs
_________________________________
Baby steps.
The fact it's in an RNS is a huge step in the right direction. Maybe, just maybe they are starting to listen to collective voice of their shareholders.
Aaaand the market doesn’t care. Ffs
WOW an RNS, please keep news coming this way, and not via Twitter. Great news...
That's more like it. RNS new products, don't tweet them.
More of the same please.
Information is king.
Yippee. SP is up 0.7%.........how dull............:((
This news is spreading, very positive indeed!